News about " preclinical development programs at Biohaven. "

Bexorg enters research collaboration with Biohaven leveraging its novel AI-driven whole-brain discovery platform to enhance CNS drug development

Bexorg enters research collaboration with Biohaven leveraging its novel AI-driven whole-brain discovery platform to enhance CNS drug development

As part of the collaboration, Bexorg’s novel whole-brain discovery platform will be used to demonstrate target engagement in relevant cell types and tissues and generate novel biomarkers, pharmacokinetic and pharmacodynamic relationships, and other mechanistic data to support two preclinical development programs at Biohaven.

Preclinical Development Programs At Biohaven. | 12/06/2025 | By Darshana 183


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members